Stock Report

Download full stock data and analysis for free Last Updated: 23-Oct-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Ipca Laboratories Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: IPCALAB | BSE: 524494

₹1,879.90

up-down-arrow ₹-23.60 (-1.24%)

As on 23-Oct-2026 12:39IST

Market cap

info icon

₹48,090 Cr

Revenue (TTM)

info icon

₹10,126 Cr

P/E Ratio

info icon

36.7

P/B Ratio

info icon

5.7

Div. Yield

info icon

0.3 %

Edit peer-selector-edit
Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Market cap (₹ Cr)
 48,090 1,11,980 1,02,937 90,536 92,989
Revenue (₹ Cr)
 10,126 28,592 33,228 34,935 14,738
Net Profit (₹ Cr)
 1,379.76 4,492.20 3,169.30 3,712.74 2,055.11
Net Margin (%)
 13.41 14.92 9.15 10.42 13.64
RoE (%)
 17.72 18.78 8.72 10.38 13.60
Price to Earnings
 36.72 24.81 31.95 24.39 45.52
Price-To-Book
 5.67 4.15 2.70 2.33 5.53

Income Statement (₹ Cr)

Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Operating Revenue arrow
10,125.58 28,591.70 33,227.90 34,935.29 14,737.88
Total Income arrow
10,292.63 30,111.40 34,650.70 35,624.79 15,061.79
Total Expenditure arrow
7,893.93 21,334.70 28,088.10 27,850.01 10,911.05
EBITDA arrow
2,231.65 7,257.00 5,139.80 7,085.28 3,826.83
Depreciation arrow
428.87 1,724.60 2,119.30 1,859.31 893.20
EBIT arrow
1,802.78 5,532.40 3,020.50 5,225.97 2,933.63
Interest arrow
69.31 510.20 416.30 387.88 578.61
Other Income arrow
167.05 1,519.70 1,422.80 689.50 323.91
Exceptional Items arrow
-86.43 -534.80 0.00 -105.51 -129.75
Profit before Tax arrow
1,814.09 6,007.10 4,027.00 5,422.08 2,549.18
Provision for Tax arrow
434.33 1,514.90 857.70 1,709.34 494.07
Profit after Tax arrow
1,379.76 4,492.20 3,169.30 3,712.74 2,055.11

Liabilities (₹ Cr)

Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Shareholder's Funds arrow
8,063.81 27,111.40 37,891.50 37,890.97 16,300.34
Minority Interest arrow
-65.36 -79.70 38.90 1.76 -24.90
Non-Current Liabilities arrow
539.20 7,112.50 3,145.10 2,580.33 5,011.23
Current Liabilities arrow
2,306.93 15,711.90 16,747.40 18,039.01 6,507.25
Total Liabilities arrow
12,349.65 50,672.60 56,576.70 58,196.15 27,754.83

Assets (₹ Cr)

Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Non-Current Assets arrow
5,384.61 31,677.20 27,204.00 24,040.45 20,274.65
Current Assets arrow
6,373.61 19,906.10 30,179.30 32,708.75 6,954.20
Total Assets arrow
12,349.65 50,672.60 56,576.70 58,196.15 27,754.83
Total Debt* arrow
703.94 11,769.50 7,734.10 7,676.20 6,021.78
Net Current Assets arrow
4,066.68 4,194.20 13,431.90 14,669.74 446.95
Contingent Liabilities arrow
249.19 989.90 336.14 1,358.37 924.77

Cashflow (₹ Cr)

Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Cash From Operating Activities arrow
1,141.97 2,116.60 5,673.70 5,526.37 3,121.29
Cash Flow from Investing Activities arrow
-246.77 -8,296.10 -6,549.30 -3,458.61 -196.42
Cash from Financing Activities arrow
-753.53 5,806.90 829.00 -1,269.15 -2,952.69
Net Cash Inflow / Outflow arrow
141.67 -372.60 -46.60 798.61 -27.82

Ratios

Profitability Ratios

 Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
ROCE (%) arrow
19.41 21.39 13.75 12.76 13.24
ROE (%) arrow
17.72 18.78 8.72 10.38 13.60
ROA (%) arrow
11.44 10.03 5.89 6.86 7.36
EBIT Margin (%) arrow
17.80 19.35 9.09 14.96 19.91
Net Margin (%) arrow
13.41 14.92 9.15 10.42 13.64
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Revenue Growth (%) arrow
10.59 21.11 -0.87 9.09 14.16
EBIT Growth (%) arrow
33.46 -8.99 -55.06 6.91 19.45
Net Profit Growth (%) arrow
67.66 -3.14 -44.66 8.63 8.09
EPS Growth (%) arrow
54.72 4.31 -43.29 11.88 12.27
Book Value Growth (%) arrow
16.05 13.19 12.99 16.04 13.74

Valuation Ratios

 Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Price / Earnings arrow
35.16 23.17 32.09 24.89 43.75
Price / Book Value arrow
5.69 4.20 2.71 2.40 5.59
Dividend Yield (%) arrow
0.32 0.09 0.65 0.25 0.04
EV/EBITDA arrow
21.41 16.23 20.26 12.79 25.62
Market Cap (₹ Cr) arrow
40,668.17 87,643.18 1,04,763.81 75,689.14 82,801.75

Solvency Ratios

 Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Debt to Equity arrow
0.01 0.12 0.00 0.02 0.17
Short term debt to equity ratio arrow
0.05 0.16 0.16 0.16 0.04
Current Ratio arrow
2.76 1.27 1.80 1.81 1.07
Quick Ratio arrow
1.58 0.91 1.35 1.15 0.74
Interest Coverage arrow
27.17 12.77 10.67 14.98 5.41

Operating Efficiency Ratios

 Ipca Laboratories Zydus Lifesciences Dr. Reddy'S Labs Aurobindo Pharma Mankind Pharma
Debtors to sales (%) arrow
19.89 18.94 30.47 20.31 11.74
Asset Turnover arrow
0.84 0.64 0.62 0.65 0.53
Receivable days arrow
73.75 33.55 103.79 33.71 39.93
Inventory Days arrow
100.11 33.80 79.94 59.32 51.78
Payable days arrow
131.14 149.82 84.78 148.20 111.46
Cash Conversion Cycle arrow
42.73 -82.46 98.95 -55.17 -19.75
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...